The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. More Details
Outstanding track record with high growth potential.
Share Price & News
How has Joint's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: JYNT has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: JYNT underperformed the US Healthcare industry which returned 16.1% over the past year.
Return vs Market: JYNT underperformed the US Market which returned 14.2% over the past year.
Price Volatility Vs. Market
How volatile is Joint's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 months ago | Simply Wall StIs The Joint Corp.'s(NASDAQ:JYNT) Recent Stock Performance Tethered To Its Strong Fundamentals?
4 months ago | Simply Wall StIf You Like EPS Growth Then Check Out Joint (NASDAQ:JYNT) Before It's Too Late
5 months ago | Simply Wall StThe Joint Corp. (NASDAQ:JYNT) Insiders Have Been Selling
Is Joint undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: JYNT ($17.3) is trading below our estimate of fair value ($26.98)
Significantly Below Fair Value: JYNT is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: JYNT is poor value based on its PE Ratio (84.7x) compared to the US Healthcare industry average (22.4x).
PE vs Market: JYNT is poor value based on its PE Ratio (84.7x) compared to the US market (18.6x).
Price to Earnings Growth Ratio
PEG Ratio: JYNT is poor value based on its PEG Ratio (1.3x)
Price to Book Ratio
PB vs Industry: JYNT is overvalued based on its PB Ratio (32.3x) compared to the US Healthcare industry average (2.9x).
How is Joint forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: JYNT's forecast earnings growth (64% per year) is above the savings rate (2.2%).
Earnings vs Market: JYNT's earnings (64% per year) are forecast to grow faster than the US market (23.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: JYNT's revenue (23.7% per year) is forecast to grow faster than the US market (9.7% per year).
High Growth Revenue: JYNT's revenue (23.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if JYNT's Return on Equity is forecast to be high in 3 years time
How has Joint performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: JYNT has high quality earnings.
Growing Profit Margin: JYNT's current net profit margins (5.4%) are higher than last year (4%).
Past Earnings Growth Analysis
Earnings Trend: JYNT has become profitable over the past 5 years, growing earnings by 56.2% per year.
Accelerating Growth: JYNT's earnings growth over the past year (71.6%) exceeds its 5-year average (56.2% per year).
Earnings vs Industry: JYNT earnings growth over the past year (71.6%) exceeded the Healthcare industry 31.1%.
Return on Equity
High ROE: JYNT's Return on Equity (37.8%) is considered high.
How is Joint's financial position?
Financial Position Analysis
Short Term Liabilities: JYNT's short term assets ($18.8M) exceed its short term liabilities ($14.8M).
Long Term Liabilities: JYNT's short term assets ($18.8M) do not cover its long term liabilities ($27.3M).
Debt to Equity History and Analysis
Debt Level: JYNT's debt to equity ratio (63%) is considered high.
Reducing Debt: JYNT's debt to equity ratio has increased from 5.1% to 63% over the past 5 years.
Debt Coverage: JYNT's debt is well covered by operating cash flow (163.3%).
Interest Coverage: Insufficient data to determine if JYNT's interest payments on its debt are well covered by EBIT.
What is Joint current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate JYNT's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate JYNT's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if JYNT's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if JYNT's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of JYNT's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Peter Holt (61 yo)
Mr. Peter D. Holt has been Chief Executive Officer of The Joint Corp. since August 11, 2016 and has been its President since January 2017. Mr. Holt served as Interim Principal Financial Officer at The Join ...
CEO Compensation Analysis
Compensation vs Market: Peter's total compensation ($USD912.69K) is about average for companies of similar size in the US market ($USD1.28M).
Compensation vs Earnings: Peter's compensation has increased by more than 20% in the past year.
|CEO, President & Director||4.08yrs||US$912.69k||1.74% |
|Chief Financial Officer||1.83yrs||US$303.41k||0.49% |
|Vice President of Operations||3.67yrs||no data||no data|
|Vice President of Marketing||no data||no data||no data|
|Vice President of Human Resources||no data||no data||no data|
|Director of Chiropractic & Compliance||4.92yrs||no data||no data|
|Vice President of Franchise Sales & Development||no data||no data||no data|
|Regional Developer for West Lake Hills||no data||no data||no data|
|Director of Real Estate Research||no data||no data||no data|
|Multi-Unit Franchisee||no data||no data||no data|
|Vice Preident of Information Technology||no data||no data||no data|
Experienced Management: JYNT's management team is considered experienced (4.1 years average tenure).
|CEO, President & Director||4.08yrs||US$912.69k||1.74% |
|Independent Director||1.33yrs||US$60.00k||2.2% |
|Independent Director||5yrs||US$85.00k||0.62% |
|Independent Director||3.25yrs||US$82.50k||0.15% |
|Independent Lead Director||3.08yrs||US$90.00k||0.19% |
|Independent Director||5.83yrs||US$92.50k||0.037% |
|Independent Director||2.25yrs||US$85.00k||0.076% |
Experienced Board: JYNT's board of directors are considered experienced (3.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
The Joint Corp.'s company bio, employee growth, exchange listings and data sources
- Name: The Joint Corp.
- Ticker: JYNT
- Exchange: NasdaqCM
- Founded: 2010
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: US$248.692m
- Shares outstanding: 14.01m
- Website: https://www.thejoint.com
Number of Employees
- The Joint Corp.
- 16767 North Perimeter Drive
- Suite 240
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|JYNT||NasdaqCM (Nasdaq Capital Market)||Yes||Common Stock||US||USD||Nov 2014|
|1JO||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Nov 2014|
The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics in the United States. The company operates through two segments, Corporate Clinics and Franchise Operations. It operates ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/09/19 06:06|
|End of Day Share Price||2020/09/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.